on 06 Dec 2022
Last Applicant/ Owned by
1551 Eastlake Avenue E, Suite 200
Seattle
WA
98102
Serial Number
90459479 filed on 11th Jan 2021
Registration Number
6919052 registered on 06th Dec 2022
Correspondent Address
Hoang-chi Truong
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of m Read More
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
01st Jan 2021
01st Jan 2021
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person
01st Jan 2021
01st Jan 2021
No 90459479
No Service Mark
No 10214-00502-
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Dec 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
06th Dec 2022 | REGISTERED-PRINCIPAL REGISTER |
29th Oct 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
28th Oct 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
27th Oct 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
26th Oct 2022 | STATEMENT OF USE PROCESSING COMPLETE |
26th Oct 2022 | SOU EXTENSION 2 GRANTED |
26th Oct 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
17th Oct 2022 | USE AMENDMENT FILED |
17th Oct 2022 | SOU EXTENSION 2 FILED |